20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Moderna's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

THE LAWSUIT: A class action securities lawsuit was filed against Moderna, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 18, ...

ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...

Moderna's,(NASDAQ:MRNA),recent 13% drop in stock price following its announcement of significant cost cuts has raised ...

Health Canada has approved an updated Novavax COVID-19 vaccine to protect against the variants of the virus currently ...